ArticleFrontiers in pharmacology2026

Repurposing ivacaftor to attenuate LPS-induced acute lung injury: evidence from a non-cystic fibrosis model.

Xiaoxuan Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.